Encio, Rosalyn .
HRN: 21-70-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2023
CEFUROXIME 500MG (TAB)
01/23/2023
01/30/2023
PO
500
Bid
Uterine Rupture
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes